SCHEMBL29010796

SCHEMBL29010796

CC1(N2C(=O)C=CC2=O)CCCCCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR1 Q9BXC0 2/20 0.36
MGLL Q99685 2/20 0.35
GSK3A P49840 1/20 0.35
GSK3B P49841 1/20 0.35
ALDH1A1 P00352 2/20 0.31
LMNA P02545 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
HSP90AA1 P07900 1/20 0.31
CCR6 P51684 1/20 0.31
CACNA1B Q00975 1/20 0.31
APBA1 Q02410 1/20 0.31
APOBEC3G Q9HC16 1/20 0.31
GMNN O75496 1/20 0.31
MAPT P10636 1/20 0.31
THPO P40225 1/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
PI4KA P42356 1/20 0.31
PI4K2B Q8TCG2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29010970 1.00 HCAR1 (0.36) HCAR1MGLLGSK3AGSK3BALDH1A1
SCHEMBL718672 1.00 HCAR1 (0.36) HCAR1MGLLGSK3AGSK3BALDH1A1
SCHEMBL29010797 0.98 MGLL (0.36) HCAR1MGLLGSK3AGSK3BALDH1A1
SCHEMBL29010976 0.93 MGLL (0.36) HCAR1MGLLGSK3AGSK3BALDH1A1
SCHEMBL29010932 0.88 MGLL (0.39) MGLLGSK3AGSK3BALDH1A1LMNA
Cyclohexane SCHEMBL28396853 0.81 ALDH1A1 (0.33) MGLLGSK3AGSK3BALDH1A1LMNA
SCHEMBL7943976 0.81 ALDH1A1 (0.33) MGLLGSK3AGSK3BALDH1A1LMNA
SCHEMBL17254419 0.75 CETP (0.30)
SCHEMBL29246382 0.74 CHRM2 (0.33)
SCHEMBL23346552 0.73 MGLL (0.35) MGLLGSK3AGSK3BALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116199747-A Lidamycin prodrug, preparation method and application thereof in preparation of antitumor drugs 中国医学科学院医药生物技术研究所 2023-06-02 CN disclosed